Speaker illustration

Doctor Marc Vanderheyden

Cardiovascular Research Center Aalst, Aalst (Belgium)

Member of:

Heart Failure Association

T cell and antibody response following double dose of BNT162b2 mRNA Vaccine in heart transplant recipients

Event: Heart Failure 2022

Topic: Heart Transplantation

Session: Heart Failure ePosters - focus on Chronic Heart Failure 6

Thumbnail

Real-world eligibility for dapagliflozin in unselected heart failure patients: data from the CORDIS-HF registry

Event: Heart Failure 2021 Online Congress

Topic: Pharmacotherapy

Session: ePoster session

Thumbnail

Functional mitral regurgitation in pts with HFrEF, HFmrEF and HFpEF: the good, the bad and the ugly ?

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Pathophysiology and Mechanisms

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

Impact of functional mitral regurgitation at discharge upon survival in patients with acute decompensated HFpEF, HFmrEF and HFrEF

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Heart Failure – Epidemiology, Prognosis, Outcome

Thumbnail

Differences in VWF activity in von willebrand disease type 2A patients versus LVAD patients with the acquired von willebrand syndrome.

Event: ESC Congress 2018

Topic: Ventricular Assist Devices

Session: Predictors of outcome after LVAD implantation

Thumbnail

Differential endomyocardial expression of SGLT1 in idiopathic dilated cardiomyopathy patients with and without diabetes mellitus.

Event: ESC Congress 2018

Topic: Pathophysiology

Session: Chronic heart failure – Pathophysiology and mechanisms

Thumbnail

Differential endomyocardial expression of SGLT1 in idiopathic dilated cardiomyopathy patients with and without diabetes mellitus.

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Pathophysiology

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

Prognostic role of myocardial SERPINA3 and ST2 transcripts in predicting mortality in patients with heart failure due to idiopathic cardiomyopathy

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure – Epidemiology, Prognosis, Outcome

Thumbnail

Differences in VWF activity in patients with von Willebrand disease type 2A versus LVAD patients with the acquired von Willebrand syndrome.

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Ventricular Assist Devices

Session: Chronic Heart Failure – Treatment

Thumbnail

Distinct differences in laboratory findings of patients with von Willebrand disease type 2A versus patients with LVAD-induced acquired von Willebrand syndrome

Event: ESC CONGRESS 2017

Topic: Circulatory assist and other

Session: Cardiovascular surgery

Thumbnail

This platform is supported by

logo Novo Nordisk